882.0000 -17.80 (-1.98%)
NSE Dec 08, 2025 15:29 PM
Volume: 141.6K
 

882.00
-1.98%
BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharmaceutic.. has an average target of 1028.50 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended